Moreover, a knock-down of TRPC3 protein by the intravenous injection of small hairpin RNAs specifically targeting TRPC3 in lentiviral particles or the application of channel blockers was also able to reduce allergy-induced airway disease [73], emphasizing the role for all three TRPC channels in allergic asthma. This evidence concerns the gene TRPC3 and allergic disease.